Stocks / GILD
GILD stock forecast
GILEAD SCIENCES INC · Healthcare · Drug Manufacturers - General
The model's rating
Outperform
GILD is rated Outperform as of September 29, 2026: its medium-term return forecast is above the middle of the stocks the model scores, but outside the top fifth.
Create a free account to compare any two stocks; the numeric score is part of Premium.
GILD is not among the 20 largest holdings published for 2026 Q4. See the portfolio
GILD against the S&P 500
| Period | GILD | S&P 500 (SPY) |
|---|---|---|
| 1 month | +2.4% | -0.3% |
| 3 months | +19.0% | +2.5% |
| Year to date | +23.6% | +12.7% |
| 1 year | +37.6% | +15.7% |
Total return, dividends included.
Key numbers
| Price | $149.05 |
| Market cap | 184.82 Billion |
| P/E (trailing 12 months) | -57.3 |
| P/S (trailing 12 months) | 6.1 |
| P/B (latest quarter) | 13.7 |
| Gross margin | 79.6% |
| Net profit margin | -10.6% |
| Return on equity | -16.3% |
| Beta | 0.3 |
As of August 6, 2026.
GILD and its closest peers
| Stock | Company | Market cap | Model rating | |
|---|---|---|---|---|
| PFE | PFIZER INC | 162.55 Billion | Greatly Outperform | GILD vs PFE |
| AMGN | AMGEN INC | 227.88 Billion | Outperform | AMGN vs GILD |
| BMY | BRISTOL MYERS SQUIBB CO | 127.47 Billion | Outperform | GILD vs BMY |
| BIIB | BIOGEN INC | 33.37 Billion | Outperform | GILD vs BIIB |
| MRK | MERCK & CO INC | 358.5 Billion | Greatly Outperform | MRK vs GILD |
| ABBV | ABBVIE INC | 462.26 Billion | Outperform |
Questions
What does the Upfront Investment model say about GILD?
The model rates GILEAD SCIENCES INC (GILD) "Outperform" as of September 29, 2026, which means its medium-term return forecast is above the middle of the stocks the model scores, but outside the top fifth. The rating is a statistical forecast, not a recommendation to buy or sell.
How is the GILD rating produced?
A machine-learning model forecasts each stock's return over the coming months and ranks the forecasts against each other. The label says where this stock's forecast falls in that ranking. It is refreshed whenever the model's data updates, normally every trading day.
Is GILD in the Upfront Investment model portfolio?
GILD is not among the 20 largest holdings published for 2026 Q4.
The rating is the output of a statistical model and can be wrong. It is not investment advice and takes no account of your circumstances. Past performance does not guarantee future results.